Patient communication of cancer genetic test results in a diverse population
Charité Ricker(Keck Hospital of USC), Gregory Idos(City Of Hope National Medical Center), Meredith Mills(Cargill (Netherlands)), Alexandra Lebensohn(National Institutes of Health), Courtney Rowe‐Teeter(Stanford University), Kerry Kingham(Cargill (Netherlands)), Katrina Lowstuter(University of Southern California), Katlyn Partynski(University of Southern California), Brian Allen(Myriad Genetics), Allison W. Kurian(Stanford University), Julie O. Culver(City of Hope), Rachel Koff(Stanford University), Stephen B. Gruber(City Of Hope National Medical Center), Anne‐Renee Hartman, Christine Hong(City Of Hope National Medical Center), Peter Levonian(Stanford University), Iva Petrovchich(Stanford University), Karlena Lara‐Otero(Stanford University), Uri Ladabaum(Stanford University), Nicolette M. Chun(Stanford University), Kevin McDonnell(City Of Hope National Medical Center), James M. Ford(Palo Alto University), Chenxu Qu(USC Norris Comprehensive Cancer Center), Duveen Sturgeon(City Of Hope National Medical Center)
Cited by 48
Related Papers
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
|Cell|2018|1.2k
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
|Clinical Cancer Research|2016|1.2k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862